Health Information Exchange: Reality and Future

Editorial Staff | | Health Exec | Informatics

March 4, 2013, 12:15 PM - 1:15 PM | Healthcare organizations looking to provide private healthcare information exchange (HIE) capabilities to their clinicians (and to potentially connect to regional, state and national exchanges) have some difficult decisions ahead.

Speaker(s):
  • Kenneth A. Kleinberg, FHIMSS
 Objectives:
  • Identify the business and technical needs for health information exchange in support of Meaningful Use and the enablement of care coordination
  • Compare the inherent strengths and challenges of the various enterprise EMR vendors, HIE vendors, speciality vendors (e.g., for e-prescribing and lab results) and payers, regarding their HIE capabilities in support of private and public exchanges
  • Recognize how HIEs will increasingly be used to support repositories, registries, data warehouses and business intelligence/analytics including population health
  • Identify the most important terminology and exchange standards that will be required for MU and for cross HIE exchange with regional, state and national HIE initiatives
  • Develop a roadmap for health information exchange success

 

Editorial Staff

Related Content

Alabama security breach exposes personal information of cardiologists, heart patients
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions
Best in KLAS 2024 rankings released, showcasing medical imaging IT systems
Cloud image storage for radiology is a growing trend in healthcare
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.